HRAS and renal cell carcinoma: We found that the expression of HRAS was upregulated in RCC cells that stably overexpressed QPCT (Figure 5C), as well as in the xenograft tumours (Figure 5D), while the expression of HRAS was downregulated when QPCT was knocked down in RCC cells (Figure 5E, Supplementary Figure 5E).